Folgen
Martin C Michel
Titel
Zitiert von
Zitiert von
Jahr
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction
M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ...
European urology 64 (1), 118-140, 2013
12792013
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
MC Michel, A Beck-Sickinger, H Cox, HN Doods, H Herzog, D Larhammar, ...
Pharmacological reviews 50 (1), 143-150, 1998
10381998
Adrenergic and muscarinic receptors in the human heart
OE Brodde, MC Michel
Pharmacological reviews 51 (4), 651-690, 1999
8891999
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
6392019
α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostate
MC Michel, W Vrydag
British journal of pharmacology 147 (S2), S88-S119, 2006
5312006
The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer
M Heger, RF van Golen, M Broekgaarden, MC Michel
Pharmacological reviews 66 (1), 222-307, 2014
4922014
The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy
KU Knowlton, MC Michel, M Itani, HE Shubeita, K Ishihara, JH Brown, ...
Journal of Biological Chemistry 268 (21), 15374-15380, 1993
3441993
Behavioral conditioning of immunosuppression is possible in humans
MU Goebel, AE Trebst, JAN Steiner, YF Xie, MS Exton, S Frede, ...
The FASEB journal 16 (14), 1869-1873, 2002
3422002
Decreased blood pressure response in mice deficient of the α1b-adrenergic receptor
A Cavalli, AL Lattion, E Hummler, M Nenniger, T Pedrazzini, JF Aubert, ...
Proceedings of the National Academy of Sciences 94 (21), 11589-11594, 1997
3341997
How reliable are G-protein-coupled receptor antibodies?
MC Michel, T Wieland, G Tsujimoto
Naunyn-Schmiedeberg's archives of pharmacology 379 (4), 385-388, 2009
3192009
Are there multiple imidazoline binding sites?
MC Michel, PA Insel
Trends in Pharmacological Sciences 10 (9), 342-344, 1989
2891989
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
2812017
A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists
MC Michel, C Foster, HR Brunner, L Liu
Pharmacological reviews 65 (2), 809-848, 2013
2812013
Receptors for neuropeptide Y: multiple subtypes and multiple second messengers
MC Michel
Trends in pharmacological sciences 12, 389-394, 1991
2791991
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis
JN Cornu, P Abrams, CR Chapple, RR Dmochowski, GE Lemack, ...
European urology 62 (5), 877-890, 2012
2722012
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability
CR Chapple, L Cardozo, VW Nitti, E Siddiqui, MC Michel
Neurourology and urodynamics 33 (1), 17-30, 2014
2682014
Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process
LJ Van Tits, MC Michel, H Grosse-Wilde, M Happel, FW Eigler, A Soliman, ...
American Journal of Physiology-Endocrinology And Metabolism 258 (1), E191-E202, 1990
2681990
Peripheral adrenergic receptors in hypertension.
MC Michel, OE Brodde, PA Insel
Hypertension 16 (2), 107-120, 1990
2501990
Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia
MC Michel, L MEHLBURGER, H SCHUMACHER, HU BRESSEL, ...
The Journal of urology 163 (6), 1725-1729, 2000
2412000
The concise guide to PHARMACOLOGY 2015/16: Overview
SPH Alexander, E Kelly, N Marrion, JA Peters, HE Benson, E Faccenda, ...
British journal of pharmacology 172 (24), 5729-5743, 2015
2362015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20